Choose how you’d like to begin
CGM program
Optimise metabolism in real time with sensors
Advanced Blood Test
Get your baseline health report and personalised plan
Wegovy and Vively are often discussed in the same weight-loss conversation, but they are not equivalent tools. Wegovy is a prescription treatment designed for chronic weight management, while Vively is a program built around glucose awareness and lifestyle change.
Comparing them side by side can help clarify which approach fits different needs, preferences, and levels of clinical support.
Key takeaways:
Wegovy is a prescription medicine containing semaglutide. It is taken as a once-weekly injection and is intended to be used with a reduced-calorie diet and increased physical activity as part of long-term weight management.
Wegovy works mainly by reducing appetite and helping people feel fuller sooner, which can make it easier to reduce overall intake. For some people, that appetite support can be the difference between repeated cycles of effort and a plan they can maintain long enough to see results.
Wegovy launched in Australia from early August 2024. It is prescribed under medical guidance, and access can depend on eligibility, supply, and the clinical context.
Wegovy is a medication, so the decision to use it should be made with a clinician who can assess risks, contraindications, and suitability. Like other GLP-1 medicines, common side effects can include gastrointestinal symptoms, and there are important safety warnings in official product information.
It also does not automatically teach the daily behaviours that support weight maintenance, so many people still benefit from structured support around meals, movement, and habits.
Vively is a metabolic health program designed for people who want to improve weight outcomes, energy, and metabolic health through practical lifestyle change. It is not positioned for insulin dosing or insulin-dependent diabetes management.
The Vively CGM Program uses the SIBIONICS G3 (GS3) sensor paired with the Vively app, so glucose data can be interpreted alongside daily habits like meals, movement, sleep, and stress. The program is $125.
Vively focuses on helping people understand patterns, not chase perfect numbers. Instead of appetite suppression, the goal is to build awareness of what drives glucose swings and cravings, then apply that insight to day-to-day choices that actually feel doable.
Core elements typically include:
Wegovy may make more sense when weight management requires a clinically supervised appetite-support pathway, especially when lifestyle-only strategies have not been enough and a clinician agrees it is appropriate.
Vively may make more sense when the goal is to understand everyday drivers of weight change, cravings, energy dips, and metabolic patterns, then build habits that can be sustained without relying on medication-led appetite suppression.
Some people also use these approaches at different times in their journey. A clinician can help decide what is appropriate and safe.
Wegovy is a prescription medicine and should only be used under medical guidance. People who are pregnant, planning pregnancy, breastfeeding, have significant gastrointestinal disease, or take glucose-altering medications should speak with a healthcare professional before starting any weight-loss or metabolic program.
CGMs measure glucose in interstitial fluid (not direct blood), and readings can lag behind blood glucose changes. If symptoms do not match CGM readings, follow clinical advice and confirm with appropriate testing when needed.
Wegovy and Vively are designed for different needs. Wegovy is a medication-led tool used under medical supervision to support long-term weight management.
Vively is a program-led approach that uses the SIBIONICS G3 (GS3) CGM sensor and app-based guidance to help people understand glucose patterns and build sustainable lifestyle changes. The Vively CGM Program is $125.
If the goal is clinical appetite support, a prescriber can advise whether Wegovy is appropriate. If the goal is insight-led behaviour change and preventative metabolic support, Vively is designed around that more practical, habit-focused path.
Curious how your daily habits affect your glucose? Explore the Vively CGM Program and turn real-time insights into healthier habits.
Subscribe to our newsletter & join a community of 20,000+ Aussies
Wegovy and Vively are often discussed in the same weight-loss conversation, but they are not equivalent tools. Wegovy is a prescription treatment designed for chronic weight management, while Vively is a program built around glucose awareness and lifestyle change.
Comparing them side by side can help clarify which approach fits different needs, preferences, and levels of clinical support.
Key takeaways:
Wegovy is a prescription medicine containing semaglutide. It is taken as a once-weekly injection and is intended to be used with a reduced-calorie diet and increased physical activity as part of long-term weight management.
Wegovy works mainly by reducing appetite and helping people feel fuller sooner, which can make it easier to reduce overall intake. For some people, that appetite support can be the difference between repeated cycles of effort and a plan they can maintain long enough to see results.
Wegovy launched in Australia from early August 2024. It is prescribed under medical guidance, and access can depend on eligibility, supply, and the clinical context.
Wegovy is a medication, so the decision to use it should be made with a clinician who can assess risks, contraindications, and suitability. Like other GLP-1 medicines, common side effects can include gastrointestinal symptoms, and there are important safety warnings in official product information.
It also does not automatically teach the daily behaviours that support weight maintenance, so many people still benefit from structured support around meals, movement, and habits.
Vively is a metabolic health program designed for people who want to improve weight outcomes, energy, and metabolic health through practical lifestyle change. It is not positioned for insulin dosing or insulin-dependent diabetes management.
The Vively CGM Program uses the SIBIONICS G3 (GS3) sensor paired with the Vively app, so glucose data can be interpreted alongside daily habits like meals, movement, sleep, and stress. The program is $125.
Vively focuses on helping people understand patterns, not chase perfect numbers. Instead of appetite suppression, the goal is to build awareness of what drives glucose swings and cravings, then apply that insight to day-to-day choices that actually feel doable.
Core elements typically include:
Wegovy may make more sense when weight management requires a clinically supervised appetite-support pathway, especially when lifestyle-only strategies have not been enough and a clinician agrees it is appropriate.
Vively may make more sense when the goal is to understand everyday drivers of weight change, cravings, energy dips, and metabolic patterns, then build habits that can be sustained without relying on medication-led appetite suppression.
Some people also use these approaches at different times in their journey. A clinician can help decide what is appropriate and safe.
Wegovy is a prescription medicine and should only be used under medical guidance. People who are pregnant, planning pregnancy, breastfeeding, have significant gastrointestinal disease, or take glucose-altering medications should speak with a healthcare professional before starting any weight-loss or metabolic program.
CGMs measure glucose in interstitial fluid (not direct blood), and readings can lag behind blood glucose changes. If symptoms do not match CGM readings, follow clinical advice and confirm with appropriate testing when needed.
Wegovy and Vively are designed for different needs. Wegovy is a medication-led tool used under medical supervision to support long-term weight management.
Vively is a program-led approach that uses the SIBIONICS G3 (GS3) CGM sensor and app-based guidance to help people understand glucose patterns and build sustainable lifestyle changes. The Vively CGM Program is $125.
If the goal is clinical appetite support, a prescriber can advise whether Wegovy is appropriate. If the goal is insight-led behaviour change and preventative metabolic support, Vively is designed around that more practical, habit-focused path.
Curious how your daily habits affect your glucose? Explore the Vively CGM Program and turn real-time insights into healthier habits.
Get irrefutable data about your diet and lifestyle by using your own glucose data with Vively’s CGM Program. We’re currently offering a 20% discount for our annual plan. Sign up here.
Co-Founder & CEO
Vively is reimagining how healthcare is delivered with the world's first online holistic healthcare clinic.
Discover how controlling your glucose levels can aid in ageing gracefully. Learn about the latest research that links glucose levels and ageing, and how Vively, a metabolic health app, can help you manage your glucose and age well.
Delve into the concept of mindful eating and discover its benefits, including improved glucose control and healthier food choices. Learn about practical strategies to implement mindful eating in your daily life.
Understand the nuances of polycystic ovary syndrome (PCOS) testing in Australia, the importance of early diagnosis, and the tests used to effectively diagnose the condition. Also, find out when these diagnostic procedures should be considered.
.png)
.svg)
Vively is a general wellness platform and does not provide medical advice, diagnosis, or treatment. Any information, insights or guidance offered through our app, website, programs, or coaches is for educational and informational purposes only and should not be considered a substitute for professional medical advice or care. Always consult a qualified healthcare provider before making any health-related decisions.
We acknowledge the Traditional Custodians of the lands where we live and work, the Gadigal of the Eora Nation. We pay our respects to their Elders past and present.
Share
Tweet
Share
